Literature DB >> 23007621

Anaemia: Does the KDIGO guideline move the needle in CKD anaemia?

Ajay K Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23007621     DOI： 10.1038/nrneph.2012.218

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  8 in total

1.  ESAs in dialysis patients: are you a hedgehog or a fox?

Authors:  Ajay K Singh
Journal:  J Am Soc Nephrol       Date:  2010-04       Impact factor: 10.121

2.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Authors:  Tilman B Drüeke; Francesco Locatelli; Naomi Clyne; Kai-Uwe Eckardt; Iain C Macdougall; Dimitrios Tsakiris; Hans-Ulrich Burger; Armin Scherhag
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

3.  Does TREAT give the boot to ESAs in the treatment of CKD anemia?

Authors:  Ajay K Singh
Journal:  J Am Soc Nephrol       Date:  2009-12-24       Impact factor: 10.121

4.  Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.

Authors:  Hicham Skali; Hans-Henrik Parving; Patrick S Parfrey; Emmanuel A Burdmann; Eldrin F Lewis; Peter Ivanovich; Sai Ram Keithi-Reddy; Janet B McGill; John J V McMurray; Ajay K Singh; Scott D Solomon; Hajime Uno; Marc A Pfeffer
Journal:  Circulation       Date:  2011-11-21       Impact factor: 29.690

5.  Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.

Authors:  Daniel W Coyne; Toros Kapoian; Wadi Suki; Ajay K Singh; John E Moran; Naomi V Dahl; Adel R Rizkala
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

6.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

7.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

Authors:  A Besarab; W K Bolton; J K Browne; J C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

8.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245
  8 in total
  2 in total

Review 1.  Drug development: how academia, industry and authorities interact.

Authors:  Silvio Garattini; Norberto Perico
Journal:  Nat Rev Nephrol       Date:  2014-08-05       Impact factor: 28.314

2.  Anemia among Chinese patients with chronic kidney disease and its association with quality of life - results from the Chinese cohort study of chronic kidney disease (C-STRIDE).

Authors:  Yan Shen; Jinwei Wang; Jing Yuan; Li Yang; Fangfang Yu; Xiaolei Wang; Ming-Hui Zhao; Luxia Zhang; Yan Zha
Journal:  BMC Nephrol       Date:  2021-02-22       Impact factor: 2.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.